Score Breakdown
Offering Ability
46
Cash Runway
95
Float Risk
57
Warrant Exposure
70
Convertible Debt
35
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 61%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.04 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.7 months cash remaining
📜 Warrant Exercise
model 50%
• Massive warrant overhang: 35% of shares outstanding
• Elevated warrant risk score (70/100)
Market Data
Market Cap$56.2K
Shares Outstanding1.61M
Float889.2K
Cash$85.6K
Debt$4.27M
Short InterestN/A
Institutional Holdings
2.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest1.5K
Days to Cover1.0
% of Float0.2%
FINRA data as of Jul 15, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2024-12-31
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual SIGY Dilution Snapshot
Sigyn Therapeutics, Inc. (SIGY) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 559,839.
- Recent SEC activity tracked for SIGY: xbrl on 2024-12-31; xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: